医学
PCSK9
心脏病学
经皮冠状动脉介入治疗
心肌梗塞
内科学
传统PCI
再灌注损伤
生物标志物
缺血
磁共振成像
放射科
低密度脂蛋白受体
脂蛋白
胆固醇
化学
生物化学
作者
Christina Tiller,Magdalena Holzknecht,Ivan Lechner,F Oberhollenzer,Sebastian von der Emde,Thomas Kremser,Can Gollmann‐Tepeköylü,Agnes Mayr,Axel Bauer,Bernhard Metzler,Sebastian J. Reinstadler,Martin Reindl
出处
期刊：Circulation-cardiovascular Imaging
[Ovid Technologies (Wolters Kluwer)]
日期：2024-08-01
卷期号：17 (8)
被引量：2
标识
DOI：10.1161/circimaging.123.016482
摘要
Beyond therapeutic implications, PCSK9 (proprotein convertase subtilisin/kexin 9) has emerged as a promising cardiovascular biomarker. The exact role of PCSK9 in the setting of acute ST-elevation myocardial infarction (STEMI) is incompletely understood. We aimed to investigate the association of PCSK9 with ischemia-reperfusion injury, visualized by cardiac magnetic resonance imaging, in patients with STEMI revascularized by primary percutaneous coronary intervention (PCI).
科研通智能强力驱动
Strongly Powered by AbleSci AI
带头大哥
跳跃仙人掌
张三坟
从容芮
薰硝壤
一一
可靠之玉
Singularity
yufanhui
干净的铅笔
w_
不懈奋进
InfoNinja
reflux
敬老院N号
坚强的广山
stuffmatter
简洁
科研文献搬运工
1257
皖公网安备34019202002308
